Inactive Instrument
United Mines, Inc. Stock OTC Bulletin Board
Stocks
US9110101063
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Market Cap | 3.26M 2.83M 2.63M 2.42M 4.57M 310M 4.63M 30.96M 12.15M 155M 12.25M 11.98M 514M | P/E 2024 |
-7.8x | P/E 2025 | -4.28x |
|---|---|---|---|---|---|
| Enterprise Value | 3.75M 3.25M 3.03M 2.78M 5.25M 356M 5.31M 35.56M 13.96M 178M 14.08M 13.77M 591M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
40.53% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Glenn Martin
CEO | Chief Executive Officer | 73 | 2014-09-29 |
Nicole Breen
SEC | Corporate Secretary | 49 | 2014-09-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Nicole Breen
BRD | Director/Board Member | 49 | 2004-12-31 |
Glenn Martin
BRD | Director/Board Member | 73 | 2004-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.90% | -2.33% | +0.68% | +14.52% | 48B | ||
| +1.26% | +8.68% | +412.19% | +563.39% | 41.13B | ||
| +3.83% | -3.90% | +29.34% | +8.48% | 37.56B | ||
| +1.80% | +0.67% | +7.22% | +75.67% | 35.91B | ||
| +2.42% | +7.27% | +14.90% | +44.79% | 29.86B | ||
| +0.16% | -2.49% | - | - | 16.12B | ||
| +0.84% | -0.80% | +32.99% | +122.83% | 16.05B | ||
| +1.25% | +1.52% | +4.62% | +18.66% | 13.76B | ||
| +4.04% | -7.96% | -1.19% | -34.81% | 12.1B | ||
| Average | +1.79% | -2.15% | +62.60% | +101.69% | 27.83B | |
| Weighted average by Cap. | +1.73% | -1.29% | +82.65% | +128.21% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -511K -442K -412K -379K -716K -48.56M -724K -4.85M -1.9M -24.3M -1.92M -1.88M -80.47M | -1.37M -1.19M -1.11M -1.02M -1.92M -130M -1.95M -13.02M -5.11M -65.28M -5.15M -5.04M -216M |
| Net Debt | 292K 253K 236K 217K 410K 27.78M 414K 2.77M 1.09M 13.9M 1.1M 1.07M 46.04M | 485K 420K 392K 360K 680K 46.11M 687K 4.6M 1.81M 23.07M 1.82M 1.78M 76.41M |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
















